AstraZeneca to Invest $245 Million in Deal With Cellectis
By Ben Otto British drugmaker AstraZeneca plans to invest $245 million in a deal with biotechnology company Cellectis to develop next-generation therapeutics...
Source: marketwatch.com
Paris Based Cellectis News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Paris Based Cellectis. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Paris Based Cellectis Today - Breaking & Trending Today